STOCK TITAN

Baldwin Insurance Group Insider Award: 645 Shares to Director

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Baldwin Insurance Group (BWIN) – Form 4 insider transaction

Director Sunita Parasuraman reported one transaction dated 07/01/2025. The filing shows an award of 645 Class A common shares at a stated price of $0.00, indicating it was likely part of an equity compensation program rather than an open-market purchase. Following the award, the director’s direct beneficial ownership rises to 10,102 shares. No dispositions, derivative securities, or additional transactions were disclosed. Aside from the routine certification language, the document contains no further financial or strategic commentary.

Positive

  • None.

Negative

  • None.

Insights

TL;DR: Routine equity grant; immaterial impact on valuation.

The filing records a small share award to a non-executive director, increasing ownership by roughly 6.8% to 10,102 shares. The award cost is zero, so no market signal from personal capital deployment exists. With BWIN’s public float presumably in the tens of millions, 645 shares is immaterial and unlikely to influence supply-demand dynamics or investor perception. No derivative activity or sales accompany the grant, reinforcing its routine nature. I view the disclosure as neutral for valuation and sentiment.

Insider Parasuraman Sunita
Role Director
Type Security Shares Price Value
Grant/Award Class A Common Stock 645 $0.00 --
Holdings After Transaction: Class A Common Stock — 10,102 shares (Direct)
Footnotes (1)
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Parasuraman Sunita

(Last) (First) (Middle)
C/O THE BALDWIN INSURANCE GROUP, INC.
4211 W. BOY SCOUT BLVD., SUITE 800

(Street)
TAMPA FL 33607

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Baldwin Insurance Group, Inc. [ BWIN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
07/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 07/01/2025 A 645 A $0 10,102 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Seth Cohen, as Attorney-in-Fact, for Sunita Parasuraman 07/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Who was the insider involved in Baldwin Insurance Group’s Form 4?

Director Sunita Parasuraman was the reporting person.

How many BWIN shares did the director acquire?

The filing reports an award of 645 Class A common shares.

What price was paid for the shares?

The shares were awarded at $0.00 per share, typical of a compensation grant.

What is the director’s total BWIN shareholding after the transaction?

After the grant, the director directly owns 10,102 shares.

Were any derivative securities reported in this Form 4?

No, no derivative securities were acquired or disposed of.